Table 4.
Post-sepsis mortality
Sepsis cohort (n=301) | |
---|---|
Early Death (< 14 days) | 13/301 (4.3%) |
MOF | 8 (62%) |
End-stage vascular disease | 3 (23%) |
Respiratory failure/ARDS | 2 (15%) |
Involved withdrawal of care | 9/13 (69%) |
30-day mortality | 29/301 (9.6%) |
MOF | 17 (59%) |
End-stage vascular disease | 4 (14%) |
Respiratory failure/ARDS | 2 (7%) |
Heart failure | 1 (3%) |
Involved withdrawal of care | 23/29 (79%) |
>30-day mortality (late deaths) | 34/301 (11.3%) |
Late MOF | 8 (24%) |
End-stage cancer | 7 (21%) |
Sepsis (recurrent) | 7 (21%) |
Heart failure/MI | 5 (15%) |
End-stage vascular disease | 3 (9%) |
Renal Failure | 2 (6%) |
CVA | 2 (6%) |
Unknown | 2 (6%) |
Involved withdrawal of care | 18/34 (53%) |
Overall 12-month mortality | 63/301 (20.9%) |
Late MOF (not infection related) | 23 (37%) |
Sepsis (recurrent) | 12 (32%) |
End-stage cancer | 7 (11%) |
End-stage vascular disease | 7 (11%) |
Heart failure/MI | 6 (10%) |
Respiratory failure | 2 (3%) |
Renal failure | 2 (3%) |
CVA | 2 (3%) |
Unknown | 2 (3%) |
Involved withdrawal of care | 41/63 (65%) |